Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Nov 6;69(19):1873-80.
doi: 10.1212/01.wnl.0000279333.77404.d7.

Association of statin use with cognitive decline in elderly African Americans

S J Szwast  1 , H C Hendrie, K A Lane, S Gao, S E Taylor, F Unverzagt, J Murrell, M Deeg, A Ogunniyi, M R Farlow, K S Hall
Affiliations

Association of statin use with cognitive decline in elderly African Americans

S J Szwast et al. Neurology. .

Abstract

Background: Previously reported associations between statin use and incident dementia or cognitive decline have been inconsistent. We report the results from a 3-year prospective study on the association of statin use on cognitive decline and incident dementia in elderly African Americans.

Methods: A community-based cohort of 1,146 African Americans aged 70 and older living in Indianapolis, Indiana, was evaluated in 2001 and 2004. The instrument used for cognitive assessment was the Community Screening Interview for Dementia (CSI-D). Cognitive decline was defined as CSI-D scores measured at 2001 minus scores at 2004. Measurements of low-density lipoprotein cholesterol (LDL-C) and C-reactive protein (CRP) were obtained from baseline blood samples.

Results: Adjusting for age at baseline, gender, education, and the possession of ApoE epsilon 4 allele, baseline statin use was associated with less cognitive decline (p = 0.0177). There were no significant interactions of statin use when LDL-C and CRP were included. Logistic regression with the four independent variables showed that statin use may be associated with a reduction in incident dementia (OR = 0.32; p = 0.0673). Association with cognitive decline was less clear when investigating statin use over time. Significance remained only for those who discontinued prior to follow-up compared to continuous users or users who started after baseline.

Conclusions: The relationship between statin use and cognitive decline is complex and subjected to unknown confounders. This effect may not be associated with the cholesterol lowering or anti-inflammatory action of statins.

PubMed Disclaimer

References

    1. Heart Protection Study Collaborative, G MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial [see comment] [summary for patients in Curr Cardiol Rep 2002;4:486–487; PMID: 12379169] Lancet. 2002;360:7–22. - PubMed
    1. Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart Protection Study Collaborative, G. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions [see comment] Lancet. 2004;363:757–767. - PubMed
    1. Dufouil C, Richard F, Fievet N, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology. 2005;64:1531–1538. - PubMed
    1. Green RC, McNagny SE, Jayakumar P, Cupples A, Benke K, Farrer LA. Statin use and the risk of Alzheimer's disease: The MIRAGE Study. Alzheimer's and Dementia. 2006;2:96–103. - PubMed
    1. Hajjar I, Schumpert J, Hirth V, Wieland D, Eleazer GP. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J Gerontol Ser A Biol Sci Med Sci. 2002;57:M414–418. - PubMed

MeSH terms

Substances